MSH2 and Lynch syndrome: Another case is described in a subset of Lynch syndrome patients where deletion of the upstream EPCAM (epithelial cellular adhesion molecule) gene leads to expression of EPCAM/MSH2 (MutS homolog 2) fusion transcripts, MSH2 promoter methylation and inhibition of MSH2 expression (Cini et al., 2019).